DR. MAHER MAHMOUDDERMATOLOGY · LASER
TeN TV#vitiligo#laser#pigmentation

Special interview on the latest vitiligo treatments and whether vitiligo is contagious

لقاء خاص مع د. ماهر محمود إستشاري الأمراض الجلدية حول أحدث علاج للبهاق

Broadcast
Program
Bent El-Balad

About this appearance

Full 23-minute studio interview (also included in the 56-minute full episode and 3.5-minute clip) addressing vitiligo pathophysiology, confirming it is completely non-contagious, and reviewing targeted topical, excimer laser, and surgical repigmentation protocols.

Open on YouTube

General information, not a diagnosis. For advice about your own skin, book a consultation. Book a consultation

CBC — Doctor HealthDoctor Health Echo

Depigmentation ("unifying skin color") in vitiligo: medical solution or psychological decision?

توحيد لون البشرة في البهاق.. حل طبي ولا قرار نفسي؟

Studio interview (5m 18s / 5m 34s) explaining when depigmentation (`توحيد لون البشرة`) is medically indicated in vitiligo (only when repigmentation fails and vitiligo covers >30–50% of exposed areas), why depigmenting creams must be applied with gloves so caregivers do not develop chemical vitiligo, Q-switched laser for residual dark spots, and debunking the myth of "skin-whitening/unifying injections" (`إبر توحيد اللون`).

Open on YouTube
CBC — Doctor HealthDoctor Health

Vitiligo problems, treatment methods, and restoring skin pigment

مشاكل البهاق وطرق علاجه واستعادة لون البشرة / د.ماهر محمود

Studio interview (4m 51s) on *Doctor Health* explaining autoimmune vitiligo triggers (psychological stress, 5% direct parental inheritance vs. 30% extended family history, links to thyroid disease, Type 1 diabetes, and colitis), the July 2022 FDA approval of targeted JAK1/JAK2 inhibitors (topical cream and 5 oral drugs), and targeted excimer laser therapy safe for children and pregnant women.

Open on YouTube
Al-NaharAl-Setat

Vitiligo causes, JAK inhibitors, and melanocyte transplantation

مشاكل البهاق الاسباب و طرق العلاج

Full 14-minute studio interview with before-and-after clinical cases demonstrating repigmentation within 1–6 months using topical JAK1/JAK2 inhibitor cream (`Ruxtop`), bergamot oil, and targeted excimer laser, plus in-clinic surgical melanocyte cell-suspension transplantation under local anesthesia for stable vitiligo.

Open on YouTube

All appearancesBook a consultation